Marshall, Alison
Lindsay, Rebecca
Clementi, Michelle A.
Gelfand, Amy A.
Orr, Serena L.
Funding for this research was provided by:
Alberta Children's Hospital Research Institute (Start-up funds)
Cumming School of Medicine, University of Calgary (Start-up funds, Department of Pediatrics)
Article History
Accepted: 30 June 2022
First Online: 26 August 2022
Declarations
:
: Alison Marshall: none.Rebecca Lindsay: none.Michelle A. Clementi: has research funding from the Ludeman Family Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus and from NIH/NCATS Colorado CTSA Grant Number UL1 TR002535. Contents are the authors’ sole responsibility and do not necessarily represent official NIH views.Amy A. Gelfand: in the last 24 months, Dr. Gelfand has received honoraria from UpToDate (for authorship), and stipends from <i>JAMA Neurology</i> for editorial work (last in July 2020) and from the American Headache Society for her role as Editor of <i>Headache</i>. She received grant support from the Duke Clinical Research Institute and the UCSF Resource Allocation Program. Her spouse reports research support (to UCSF) from Genentech for a clinical trial, honoraria for editorial work from Dynamed Plus, and personal compensation for medical-legal consulting.Serena L. Orr receives royalties from Cambridge University Press. She serves on the editorial boards of <i>Headache</i> and <i>Neurology</i>. She also has research funding from the Canadian Institutes of Health Research and the Alberta Children’s Hospital Research Institute.
: This article does not contain any studies with human or animal subjects performed by any of the authors.